US Stock MarketDetailed Quotes
CCRN Cross Country Healthcare
- 15.030
- -0.080-0.53%
Trading Aug 30 12:06 ET
508.14MMarket Cap60.12P/E (TTM)
15.210High14.960Low73.65KVolume15.210Open15.110Pre Close1.11MTurnover0.23%Turnover Ratio7.33P/E (Static)33.81MShares25.76052wk High1.16P/B476.50MFloat Cap12.87052wk Low--Dividend TTM31.70MShs Float40.120Historical High--Div YieldTTM1.66%Amplitude3.760Historical Low15.030Avg Price1Lot Size
Cross Country Healthcare Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -37.16%339.77M | -39.11%379.17M | -28.04%2.02B | -34.09%414.04M | -30.47%442.29M | -28.25%540.7M | -21.05%622.71M | 67.39%2.81B | -1.94%628.22M | 69.67%636.1M |
| Operating revenue | -37.16%339.77M | -39.11%379.17M | -28.04%2.02B | -34.09%414.04M | -30.47%442.29M | -28.25%540.7M | -21.05%622.71M | 67.39%2.81B | -1.94%628.22M | 69.67%636.1M |
| Cost of revenue | -35.59%268.97M | -37.54%301.88M | -27.98%1.57B | -33.87%323.55M | -29.97%344.93M | -28.40%417.56M | -21.28%483.28M | 67.40%2.18B | -0.86%489.28M | 69.20%492.55M |
| Gross profit | -42.50%70.81M | -44.56%77.3M | -28.24%450.41M | -34.87%90.49M | -32.18%97.36M | -27.74%123.14M | -20.24%139.42M | 67.38%627.69M | -5.58%138.94M | 71.31%143.55M |
| Operating expense | -22.06%64.98M | -23.85%67.89M | -5.56%318.74M | -14.78%72.04M | -11.62%74.17M | -6.84%83.37M | 12.05%89.16M | 49.20%337.51M | 21.52%84.53M | 51.13%83.92M |
| Selling and administrative expenses | -23.66%60.26M | -24.93%63.25M | -7.55%300.39M | -16.96%67.57M | -13.73%69.63M | -8.22%78.94M | 9.64%84.26M | 50.18%324.94M | 21.73%81.37M | 52.72%80.71M |
| Depreciation amortization depletion | 6.48%4.72M | -5.34%4.64M | 45.89%18.35M | 41.40%4.47M | 41.26%4.54M | 27.32%4.43M | 80.36%4.9M | 27.65%12.58M | 16.25%3.16M | 19.93%3.21M |
| -Depreciation and amortization | 6.48%4.72M | -5.34%4.64M | 45.89%18.35M | 41.40%4.47M | 41.26%4.54M | 27.32%4.43M | 80.36%4.9M | 27.65%12.58M | 16.25%3.16M | 19.93%3.21M |
| Operating profit | -85.35%5.83M | -81.29%9.4M | -54.62%131.67M | -66.09%18.45M | -61.10%23.19M | -50.85%39.77M | -47.22%50.26M | 95.03%290.18M | -29.87%54.41M | 110.94%59.63M |
| Net non-operating interest income expense | 81.96%-568K | 87.48%-462K | 43.76%-8.09M | 83.33%-586K | 80.87%-669K | 18.36%-3.15M | -4.80%-3.69M | -109.60%-14.39M | -24.78%-3.52M | -60.31%-3.5M |
| Non-operating interest expense | -81.96%568K | -87.48%462K | -43.76%8.09M | -83.33%586K | -80.87%669K | -18.36%3.15M | 4.80%3.69M | 109.60%14.39M | 24.78%3.52M | 60.31%3.5M |
| Other net income (expense) | -293.13%-24.82M | 18.57%-5.25M | -6.30%-20.68M | -7.67%-4.9M | 59.28%-3.02M | -117.27%-6.31M | -40.77%-6.45M | -123.33%-19.46M | -208.97%-4.55M | -413.70%-7.42M |
| Special income (charges) | -297.18%-25.03M | -0.31%-6.48M | 0.54%-20.68M | -5.52%-5.03M | 61.22%-2.89M | -57.97%-6.3M | -40.78%-6.46M | -119.29%-20.8M | -193.05%-4.77M | -309.34%-7.45M |
| -Less：Restructuring and merger&acquisition | 131.76%2.12M | 118.65%938K | 37.18%2.55M | 43,050.00%863K | -86.04%348K | 181.96%913K | -10.63%429K | -29.24%1.86M | 100.27%2K | 557.78%2.49M |
| -Less:Other special charges | 129.02%3.95M | 224.44%3.65M | -23.61%2.85M | --0 | ---- | -9.88%1.72M | --1.13M | --3.73M | --1.82M | ---- |
| -Write off | 417.37%18.97M | -61.41%1.89M | 0.49%15.28M | 41.33%4.17M | -48.74%2.54M | 14.88%3.67M | 19.42%4.91M | 121.89%15.21M | 24.24%2.95M | 244.00%4.96M |
| Other non- operating income (expenses) | 2,027.27%212K | 10,150.00%1.23M | -100.15%-2K | -39.63%131K | -596.30%-134K | -101.01%-11K | 50.00%12K | 73.51%1.34M | 40.91%217K | -92.80%27K |
| Income before tax | -164.55%-19.56M | -90.80%3.69M | -59.86%102.89M | -72.02%12.97M | -59.96%19.5M | -59.13%30.31M | -53.95%40.12M | 92.42%256.33M | -36.77%46.35M | 97.66%48.7M |
| Income tax | -139.19%-3.51M | -90.67%997K | -55.41%30.26M | -48.00%3.93M | -51.92%6.69M | -57.85%8.96M | -57.50%10.68M | 5,527.20%67.86M | 276.86%7.56M | 1,052.53%13.91M |
| Net income | -175.19%-16.05M | -90.85%2.69M | -61.46%72.63M | -76.70%9.04M | -63.18%12.81M | -59.65%21.35M | -52.51%29.44M | 42.77%188.46M | -49.99%38.79M | 48.48%34.79M |
| Net income continuous Operations | -175.19%-16.05M | -90.85%2.69M | -61.46%72.63M | -76.70%9.04M | -63.18%12.81M | -59.65%21.35M | -52.51%29.44M | 42.77%188.46M | -49.99%38.79M | 48.48%34.79M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -175.19%-16.05M | -90.85%2.69M | -61.46%72.63M | -76.70%9.04M | -63.18%12.81M | -59.65%21.35M | -52.51%29.44M | 42.77%188.46M | -49.99%38.79M | 48.48%34.79M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -175.19%-16.05M | -90.85%2.69M | -61.46%72.63M | -76.70%9.04M | -63.18%12.81M | -59.65%21.35M | -52.51%29.44M | 42.77%188.46M | -49.99%38.79M | 48.48%34.79M |
| Basic earnings per share | -178.33%-0.47 | -90.24%0.08 | -59.33%2.07 | -75.47%0.26 | -60.64%0.37 | -57.45%0.6 | -50.90%0.82 | 41.39%5.09 | -49.52%1.06 | 49.21%0.94 |
| Diluted earnings per share | -178.33%-0.47 | -90.12%0.08 | -59.16%2.05 | -75.24%0.26 | -61.29%0.36 | -57.14%0.6 | -50.31%0.81 | 42.21%5.02 | -49.28%1.05 | 50.00%0.93 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg